Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer
Titel:
Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer
Auteur:
Tan, E.H. Rolski, J. Grodzki, T. Schneider, C.P. Gatzemeier, U. Zatloukal, P. Aitini, E. Carteni, G. Riska, H. Tsai, Y.H. Abratt, R.